Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

The Health and Human Services Department says the county’s Treatment Court program is ending due to an unfilled key staff ...

Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...

UNAIDS warns that cuts to HIV/AIDS funding by rich donors, including the U.S., have led some poorer nations to boost their ...

Healthcare delivery organizations are saying they have yet to fully recover financially from the COVID-19 pandemic, and a high level of uncertainty around changing regulations and economic conditions ...

Hospitals, health systems and physician practices are shifting their operational and financial strategies in the face of ...

The idea of making the U.S. more like Europe is anathema to many in the Trump administration. But that’s what the Make ...

The Independent previously revealed that new super-strength synthetic opioids now infiltrating the UK drugs market had already claimed lives behind bars, with two deaths in June 2022 at HMP Lewes ...

There were 498 opioid overdose deaths in the third quarter last year, the lowest number of deaths in a single quarter since ...

Despite an apparent reversal on mass layoffs, the Department of Veterans Affairs is quietly advancing a workforce reduction, ...